Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Harmond who wrote (80303)	10/12/1999 3:16:00 PM
From: KeepItSimple	Respond to of 164684

>Very leveragable business models. At least until the government finally comes to its senses and makes the patenting of existing human gene sequences illegal. "I own you and the genes you're made of"

To: Bill Harmond who wrote (80303)	10/12/1999 4:00:00 PM
From: Robert Rose	Read Replies (2) \| Respond to of 164684

William or anyone: My neighbor, who teaches at Stanford Med School, has been out of biotech stocks. The last time we talked stocks a couple months ago, he thought 2000 would be biotech's year. He prefers not to recommend stocks, but will comment on ones I put forth. I'll have to pass your two picks by him. At any rate, I'm hesitant to invest in biotech, given my total ignorance of the field and the voluminous amount of research it would take to get up to speed. Could you provide an overview of why it's now time to get into biotech? Do you think biotech will perform as well over the next 12 months as the inets, specifically b2b and comm infrastructure? tia, Rob